Page last updated: 2024-08-17

quinoxalines and Hematoma

quinoxalines has been researched along with Hematoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alleyne, CH; Dhandapani, KM; King, MD1
Miyata, K; Sasamata, M; Suzuki, M; Terai, K; Yamaguchi, T; Yatsugi, Si1

Other Studies

2 other study(ies) available for quinoxalines and Hematoma

ArticleYear
TNF-alpha receptor antagonist, R-7050, improves neurological outcomes following intracerebral hemorrhage in mice.
    Neuroscience letters, 2013, May-10, Volume: 542

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Cerebral Hemorrhage; Hematoma; Male; Mice; Neuroprotective Agents; Quinoxalines; Receptors, Tumor Necrosis Factor, Type I; Triazoles; Tumor Necrosis Factor-alpha

2013
Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model.
    European journal of pharmacology, 2003, Apr-25, Volume: 467, Issue:1-3

    Topics: Animals; Atrophy; Brain Edema; Brain Infarction; Cerebral Hemorrhage; Collagenases; Dose-Response Relationship, Drug; Hematoma; Heparin; Imidazoles; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA

2003